Coreg Tablet, Film Coated
Product Images NDC 80725-141

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Coreg (NDC 80725-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Coreg 01)

Chemical structure diagram of Carvedilol, the active ingredient in Coreg tablets. The diagram shows the molecular arrangement with rings and functional groups characteristic of carvedilol.*

FDA Label Image

Figure 1 (Coreg 02)

A line graph comparing percent mortality over 21 months between placebo and carvedilol groups. The x-axis represents time in months, and the y-axis shows percent mortality. The graph shows lower mortality in the carvedilol group than placebo, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure 2 (Coreg 03)

A forest plot chart depicting hazard ratios for various subgroups of patients treated with Coreg (Carvedilol). The subgroups compared include gender (men, women), age categories (<65, ≥65), race (non-black, black), diabetic status, ischemic status, heart rate levels, systolic blood pressure levels, spironolactone use, and all patients. Each subgroup has a hazard ratio with confidence intervals, plotted against a reference line at 1.0 on the horizontal axis.*

FDA Label Image

Figure 3 (Coreg 04)

A Kaplan-Meier survival curve comparing % mortality over 24 months between two groups labeled Placebo and Carvedilol. The x-axis represents time in months, and the y-axis shows % mortality. The graph indicates a statistically significant difference with P = 0.03, with the Carvedilol group showing lower mortality over time compared to Placebo.*

FDA Label Image

Figure 4 (Coreg 05)

A forest plot chart showing hazard ratios comparing different patient subgroups (age, gender, timing of randomization, prior oral beta-blocker use, Killip class, thrombolytic therapy, PTCA, CHF status, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure) with 95% confidence intervals for each subgroup. The x-axis displays hazard ratio values from 0.4 to 1.3.*

FDA Label Image

Principal Display Panel (3.125 mg Tablet Bottle Label)

Label for Coreg (carvedilol) 3.125 mg film-coated tablets by Waylis Therapeutics LLC. The prescription drug is supplied in a container of 100 tablets. Storage instructions, usage warnings, and manufacturer information are included on the label.*

FDA Label Image

Principal Display Panel (6.25 mg Tablet Bottle Label)

Coreg (carvedilol) 6.25 mg film-coated tablets label from Waylis Therapeutics LLC. The label includes product name, strength, dosage form, quantity of 100 tablets, storage instructions, a warning about the membrane seal under the cap, and the manufacturer information. It features a barcode and emphasizes the 6.25 mg strength in a green box.*

FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

Label for Coreg (carvedilol) Tablets by Waylis Therapeutics LLC, showing the 12.5 mg strength. The label includes storage instructions, a warning not to accept if the membrane seal under the cap is missing or broken, and states the package contains 100 film-coated tablets. Bar code and manufacturer location in Wixom, MI are visible.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Label for Coreg (carvedilol) Tablets 25 mg, oral film-coated tablets. The label includes storage instructions, a barcode, the NDC number 80725-142-20, and states the package contains 100 TILTAB tablets. Manufactured for Waylis Therapeutics LLC, Wixom, MI.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.